Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kyntra Bio (KYNB) Revenue (2016 - 2025)

Historic Revenue for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $1.1 million.

  • Kyntra Bio's Revenue rose 77479.67% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 million, marking a year-over-year increase of 7881.22%. This contributed to the annual value of $7.2 million for FY2024, which is 8461.64% down from last year.
  • Latest data reveals that Kyntra Bio reported Revenue of $1.1 million as of Q3 2025, which was up 77479.67% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Kyntra Bio's Revenue ranged from a high of $156.0 million in Q3 2021 and a low of -$73.8 million during Q4 2023
  • Its 5-year average for Revenue is $13.7 million, with a median of $4.0 million in 2021.
  • In the last 5 years, Kyntra Bio's Revenue plummeted by 31477.29% in 2023 and then soared by 77479.67% in 2025.
  • Kyntra Bio's Revenue (Quarter) stood at $16.5 million in 2021, then soared by 107.74% to $34.4 million in 2022, then tumbled by 314.77% to -$73.8 million in 2023, then surged by 73.87% to -$19.3 million in 2024, then soared by 105.58% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.3 million for Q2 2025, and $1.8 million during Q1 2025.